Mechanism of aminosalicylic acid action is:

Questions 52

ATI RN

ATI RN Test Bank

Cardiovascular Drugs Pharmacology Questions

Question 1 of 5

Mechanism of aminosalicylic acid action is:

Correct Answer: B

Rationale: The correct answer is B: Inhibition of folate synthesis. Aminosalicylic acid acts by inhibiting the enzyme dihydropteroate synthase in the folate synthesis pathway of bacteria. This disrupts the production of essential folate cofactors needed for DNA and RNA synthesis, ultimately leading to bacterial growth inhibition. Incorrect choices: A: Inhibition of mycolic acids synthesis - This mechanism is associated with drugs like isoniazid in the treatment of mycobacterial infections. C: Inhibition of DNA dependent RNA polymerase - This mechanism is associated with drugs like rifampin. D: Inhibition of DNA gyrase - This mechanism is associated with drugs like fluoroquinolones.

Question 2 of 5

Which of the following drugs was most likely included in the immediate medical treatment of the 63-year-old woman with symptoms of dyspnea?

Correct Answer: D

Rationale: The correct answer is D: Epinephrine. Epinephrine is a vasopressor and bronchodilator used in emergency situations like dyspnea to improve breathing and increase blood pressure. Hydrochlorothiazide and Amiloride are diuretics used to treat hypertension and edema, not acute dyspnea. Mannitol is an osmotic diuretic used to reduce intracranial pressure, not for dyspnea. Epinephrine is the most appropriate choice for immediate relief of dyspnea due to its bronchodilator effects and ability to improve breathing quickly.

Question 3 of 5

Which of the following actions best explains the potassium-sparing effect of this drug?

Correct Answer: B

Rationale: The correct answer is B: Blockade of Na+ channels in the collecting duct. This action prevents Na+ reabsorption, leading to increased Na+ in the urine and decreased K+ secretion. This mechanism is seen in potassium-sparing diuretics like amiloride and triamterene. Choices A and C do not directly impact potassium sparing. Choice D is incorrect as aldosterone receptor blockade would lead to increased K+ excretion.

Question 4 of 5

Which one of the following drugs increase digoxin plasma concentration by a pharmacokinetic mechanism?

Correct Answer: D

Rationale: The correct answer is D) Quinidine. Quinidine is known to increase digoxin plasma concentration by a pharmacokinetic mechanism. Quinidine competes with digoxin for renal tubular secretion, leading to reduced excretion of digoxin and ultimately higher plasma concentrations of digoxin. Option A) Captopril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension. It does not have a direct impact on digoxin plasma concentration. Option B) Hydrochlorothiazide is a diuretic that acts on the kidneys to increase urine output. It does not interact with digoxin to increase its plasma concentration. Option C) Lidocaine is a local anesthetic that does not affect digoxin plasma concentration through pharmacokinetic mechanisms. Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective treatment for patients. Knowing how different drugs can affect each other's pharmacokinetics helps in preventing adverse reactions and optimizing therapeutic outcomes. In this case, recognizing that quinidine can increase digoxin levels is important for managing patients who are on both medications to avoid potential toxicity.

Question 5 of 5

The action of digitalis is enhanced by

Correct Answer: B

Rationale: The correct answer is B) Calcium. To understand why, we need to delve into the pharmacology of digitalis. Digitalis, such as digoxin, is a medication commonly used in the management of heart failure and certain arrhythmias. It exerts its therapeutic effects by inhibiting the sodium-potassium ATPase pump in cardiac myocytes, leading to an increase in intracellular sodium and subsequently an increase in intracellular calcium levels. This increase in intracellular calcium enhances the contractility of the heart muscle, improving cardiac output. Calcium plays a crucial role in the mechanism of action of digitalis. Therefore, the action of digitalis is enhanced by an increase in calcium levels. This is why option B is correct. Now, let's discuss why the other options are incorrect: A) Sodium: While digitalis does affect sodium levels intracellularly, it is not the primary mechanism by which digitalis exerts its therapeutic effects. Therefore, sodium does not enhance the action of digitalis. C) Magnesium: Magnesium levels can influence cardiac function, but they do not directly enhance the action of digitalis. Magnesium is more relevant in the context of arrhythmias rather than enhancing digitalis action. D) Potassium: Potassium levels are important in cardiac function, but they do not enhance the action of digitalis. In fact, low potassium levels can increase the risk of digitalis toxicity. In an educational context, understanding the pharmacology of cardiovascular drugs like digitalis is essential for healthcare professionals, especially those involved in managing patients with heart failure or arrhythmias. Understanding how different electrolytes and ions interact with these medications can help in optimizing therapy and preventing potential complications.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions